Dew I know you have raised this issue about OXGN before but they keep proceeding and now have about 10 phase I and II studies underway. Are you still convinced this is a problem? Have the company ever publically addressed this issue? Have any of the very competant Scandinavian posters(eg. kokostrollet) ever responded?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.